Bo Kruse

Chief Financial Officer, Y-mAbs Therapeutics, Inc.

Companies

Y-mAbs Therapeutics, Inc.Chief financial officer Sep 20, 2018 to Jul 8, 2024¹
Y-mAbs Therapeutics, Inc.Board member Sep 20, 2018 to Jan 9, 2020¹

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

May 31, 2024Sold 31,371 shares at $12.07 of Y-mAbs Therapeutics, Inc.²
May 31, 2024Exercised options 31,371 shares at $2.00 of Y-mAbs Therapeutics, Inc.²
May 30, 2024Sold 28,629 shares at $12.03 of Y-mAbs Therapeutics, Inc.²
May 30, 2024Exercised options 28,629 shares at $2.00 of Y-mAbs Therapeutics, Inc.²
Jan 18, 2024Granted 18,100 shares of Y-mAbs Therapeutics, Inc.³
Jan 17, 2023Granted 11,700 shares of Y-mAbs Therapeutics, Inc.⁴
Feb 22, 2022Sold 4,000 shares at $7.85 of Y-mAbs Therapeutics, Inc.⁵
Feb 4, 2022Sold 4,000 shares at $7.97 of Y-mAbs Therapeutics, Inc.⁶
Jan 24, 2022Sold 4,000 shares at $9.84 of Y-mAbs Therapeutics, Inc.⁷
Jan 4, 2022Sold 4,000 shares at $17.12 of Y-mAbs Therapeutics, Inc.⁸
Dec 22, 2021Sold 4,000 shares at $16.36 of Y-mAbs Therapeutics, Inc.⁹
Dec 6, 2021Sold 4,000 shares at $16.35 of Y-mAbs Therapeutics, Inc.¹⁰
Nov 22, 2021Sold 4,000 shares at $18.09 of Y-mAbs Therapeutics, Inc.¹¹
Nov 4, 2021Sold 4,000 shares at $27.54 of Y-mAbs Therapeutics, Inc.¹²
Oct 22, 2021Sold 4,000 shares at $25.94 of Y-mAbs Therapeutics, Inc.¹³
Oct 4, 2021Sold 4,000 shares at $28.78 of Y-mAbs Therapeutics, Inc.¹⁴

The numbers on this page point here. Each one links to the record it came from.